{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:49:47Z","timestamp":1793227787719,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020430","name":"LG Chemical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020430","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.molmet.2023.101806","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T02:23:24Z","timestamp":1695176604000},"page":"101806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy"],"prefix":"10.1016","volume":"78","author":[{"given":"Youngmi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyekyung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Gu","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molmet.2023.101806_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","article-title":"Ethnicity and nonalcoholic fatty liver disease","volume":"55","author":"Bambha","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1467-789X.2009.00657.x","article-title":"Non-alcoholic fatty liver disease from pathogenesis to management: an update","volume":"11","author":"Musso","year":"2010","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.molmet.2023.101806_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101806_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"Ortiz-Lopez","year":"2012","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.molmet.2023.101806_bib6","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1503\/cmaj.092144","article-title":"Newly diagnosed diabetes mellitus as a risk factor for serious liver disease","volume":"182","author":"Porepa","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.molmet.2023.101806_bib8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40265-015-0437-3","article-title":"Non-alcoholic steatohepatitis: limited available treatment options but promising drugs in development and recent progress towards a regulatory approval pathway","volume":"75","author":"Filozof","year":"2015","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.molmet.2023.101806_bib9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10620-015-4025-x","article-title":"Function of autophagy in nonalcoholic fatty liver disease","volume":"61","author":"Czaja","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/j.gastro.2015.09.042","article-title":"Regulation of liver metabolism by autophagy","volume":"150","author":"Madrigal-Matute","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2023.101806_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/282041","article-title":"Lipophagy: connecting autophagy and lipid metabolism","author":"Singh","year":"2012","journal-title":"Int J Cell Biol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2023.101806_bib14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","author":"Hernandez-Gea","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/egh.11.4","article-title":"Autophagy in nonalcoholic steatohepatitis","volume":"5","author":"Amir","year":"2011","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"7382","key":"10.1016\/j.molmet.2023.101806_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature10758","article-title":"Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis","volume":"481","author":"He","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.molmet.2023.101806_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2013.01.011","article-title":"Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice","volume":"58","author":"Lin","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2023.101806_bib18","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1038\/ncomms5834","article-title":"Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers","volume":"5","author":"Park","year":"2014","journal-title":"Nat Commun"},{"issue":"25","key":"10.1016\/j.molmet.2023.101806_bib19","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.3748\/wjg.v21.i25.7754","article-title":"Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats","volume":"21","author":"Chang","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.molmet.2023.101806_bib20","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1080\/15548627.2017.1356977","article-title":"Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.molmet.2023.101806_bib21","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1742-1241.2006.01178.x","article-title":"DPP-4 inhibitors and their potential role in the management of type 2 diabetes","volume":"60","author":"Barnett","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.molmet.2023.101806_bib22","first-page":"729","article-title":"Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism","volume":"5","author":"Miyazaki","year":"2012","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.molmet.2023.101806_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1665-2681(19)31905-2","article-title":"Dipeptidyl peptidase IV (DDP IV) in NASH patients","volume":"6","author":"Balaban","year":"2007","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","article-title":"Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"54","author":"Ben-Shlomo","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcp.2015.08.098","article-title":"A\u00a0dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression","volume":"98","author":"Hwang","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101806_bib26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db10-1338","article-title":"Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice","volume":"60","author":"Shirakawa","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038744","article-title":"Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity","volume":"7","author":"Kern","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2023.101806_bib29","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2023.101806_bib30","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2337\/diabetes.54.10.2988","article-title":"Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9","volume":"54","author":"Lankas","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2023.101806_bib31","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1016\/j.molmet.2023.101806_bib32","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1194\/jlr.M600198-JLR200","article-title":"Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1","volume":"47","author":"Rizki","year":"2006","journal-title":"J\u00a0Lipid Res"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.molmet.2023.101806_bib34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ncb2788","article-title":"Emerging regulation and functions of autophagy","volume":"15","author":"Boya","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4161\/auto.6398","article-title":"Autophagy revisited: a conversation with Christian de Duve","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.molmet.2023.101806_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbalip.2016.01.006","article-title":"Autophagy, lipophagy and lysosomal lipid storage disorders","volume":"1861","author":"Ward","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2023.101806_bib37","article-title":"The role of lipophagy in the development and treatment of non-alcoholic fatty liver disease","volume":"11","author":"Grefhorst","year":"2020","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.molmet.2023.101806_bib38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","article-title":"Macrophage autophagy protects against liver fibrosis in mice","volume":"11","author":"Lodder","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.molmet.2023.101806_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.intimp.2018.01.029","article-title":"Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation","volume":"56","author":"Chen","year":"2018","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.molmet.2023.101806_bib40","article-title":"Dipeptidyl-peptidase 4 inhibitor sitagliptin ameliorates hepatic insulin resistance by modulating inflammation and autophagy in ob\/ob mice","volume":"2018","author":"Zheng","year":"2018","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.molmet.2023.101806_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12933-015-0264-6","article-title":"Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats","volume":"14","author":"Murase","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.molmet.2023.101806_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.937554","article-title":"A\u00a0randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes","volume":"9","author":"Doustmohammadian","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.molmet.2023.101806_bib43","first-page":"23","article-title":"Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial","volume":"10","author":"Alam","year":"2018","journal-title":"Hepat Med"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhep.2016.04.021","article-title":"Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"65","author":"Cui","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3748\/wjg.v23.i1.141","article-title":"Sitagliptin in patients with non-alcoholic steatohepatitis: a randomized, placebo-controlled trial","volume":"23","author":"Joy","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.molmet.2023.101806_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","article-title":"AMPK Re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development","volume":"28","author":"Boudaba","year":"2018","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.molmet.2023.101806_bib47","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1080\/15548627.2020.1827779","article-title":"Mir214-3p and Hnf4a\/Hnf4alpha reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis","volume":"17","author":"Lee","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.molmet.2023.101806_bib48","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","article-title":"Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD","volume":"5","author":"Gonzalez-Rodriguez","year":"2014","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010350","article-title":"Delayed exercise training improves obesity-induced chronic kidney disease by activating AMPK pathway in high-fat diet-fed mice","volume":"22","author":"Juszczak","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/MCB.06159-11","article-title":"Role of AMPK-mTOR-Ulk1\/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks","volume":"32","author":"Alers","year":"2012","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4161\/auto.7.1.13883","article-title":"Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt\/mTOR pathway","volume":"7","author":"Vucicevic","year":"2011","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.molmet.2023.101806_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75030-8","article-title":"Fine-tuning of AMPK-ULK1-mTORC1 regulatory triangle is crucial for autophagy oscillation","volume":"10","author":"Holczer","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/BJ20131344","article-title":"Phosphorylation by Akt within the ST loop of AMPK-alpha1 down-regulates its activation in tumour cells","volume":"459","author":"Hawley","year":"2014","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2009.11.010","article-title":"Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster","volume":"11","author":"Bjedov","year":"2010","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2023.101806_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 inflammasome and autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.molmet.2023.101806_bib60","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101806_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76497-1","article-title":"NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet","volume":"10","author":"Sokolova","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2023.101806_bib62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2021.12.065","article-title":"Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease","volume":"588","author":"Lee","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.molmet.2023.101806_bib63","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J\u00a0Lipid Res"},{"issue":"6","key":"10.1016\/j.molmet.2023.101806_bib64","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3803\/EnM.2022.1530","article-title":"Gemigliptin alleviates succinate-induced hepatic stellate cell activation by ameliorating mitochondrial dysfunction","volume":"37","author":"Nguyen","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"10.1016\/j.molmet.2023.101806_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1139\/cjpp-2016-0026","article-title":"Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice","volume":"95","author":"Choi","year":"2017","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:36:47Z","timestamp":1761957407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":65,"alternative-id":["S2212877823001400"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101806","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101806"}}